Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boreal Biomanufacturing, formerly known as the Biotherapeutics Manufacturing Centre (BMC), is a leading Canadian non-profit contract development and manufacturing organization (CDMO) owned and operated by The Ottawa Hospital. With nearly two decades of experience, the organization specializes in bridging the translational divide for advanced therapeutics, specifically cell and gene therapies, oncolytic viruses, and vaccines. Boreal operates eight GMP-compliant manufacturing suites and offers end-to-end services from process development to fill-finish. It has manufactured over 20 distinct products for clinical trials across North America, Europe, and Asia, making it a trusted partner for both academic and commercial biopharma innovators.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boreal Biomanufacturing.